New Zealand markets closed

Iovance Biotherapeutics, Inc. (IOVA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.70-0.31 (-3.10%)
At close: 04:00PM EDT
9.71 +0.01 (+0.10%)
After hours: 07:59PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
114,888
231,731
78,229
67,329
-
Other short-term investments
164,979
240,114
426,181
562,108
-
Total cash
279,867
471,845
504,410
629,437
-
Net receivables
151
0
-
-
-
Inventory
10,372
0
-
-
-
Other current assets
17,458
7,271
3,546
6,663
-
Total current assets
307,848
479,116
507,956
636,100
-
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
204,458
194,965
178,610
119,493
-
Accumulated depreciation
-27,913
-16,718
-8,689
-5,578
-
Net property, plant and equipment
176,545
178,247
169,921
113,915
-
Equity and other investments
-
0
91,588
0
-
Other long-term assets
66,700
6,619
7,868
18,443
-
Total non-current assets
472,503
184,866
269,377
132,358
-
Total assets
780,351
663,982
777,333
768,458
-
Liabilities and stockholders' equity
Liabilities
Current liabilities
Accounts payable
33,123
26,603
27,377
13,513
-
Accrued liabilities
69,406
52,295
56,766
35,074
-
Total current liabilities
110,306
91,485
89,200
54,871
-
Non-current liabilities
Long-term debt
1,000
1,000
1,000
-
-
Deferred tax liabilities
17,347
0
-
-
-
Other long-term liabilities
-
-
-
11,714
2,352
Total non-current liabilities
85,432
72,859
66,474
57,089
-
Total liabilities
195,738
164,344
155,674
111,960
-
Stockholders' equity
Common stock
14
11
10
10
-
Retained earnings
-2,012,375
-1,568,338
-1,172,445
-830,193
-
Accumulated other comprehensive income
2,526
-902
-601
19
-
Total stockholders' equity
584,613
499,638
621,659
656,498
-
Total liabilities and stockholders' equity
780,351
663,982
777,333
768,458
-